D. A. Horbach

742 total citations
13 papers, 574 citations indexed

About

D. A. Horbach is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, D. A. Horbach has authored 13 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 7 papers in Hematology and 4 papers in Genetics. Recurrent topics in D. A. Horbach's work include Systemic Lupus Erythematosus Research (9 papers), Blood disorders and treatments (4 papers) and Platelet Disorders and Treatments (4 papers). D. A. Horbach is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Blood disorders and treatments (4 papers) and Platelet Disorders and Treatments (4 papers). D. A. Horbach collaborates with scholars based in Netherlands, United Kingdom and Poland. D. A. Horbach's co-authors include Erica van Oort, Ronald H. W. M. Derksen, Philip G. de Groot, R. H. W. M. Derksen, Philip de Groot, P G de Groot, Ton Lisman, Mariëlle J. Tempelman, Edouard M. Bevers and Joost C. M. Meijers and has published in prestigious journals such as Neurology, British Journal of Haematology and Thrombosis and Haemostasis.

In The Last Decade

D. A. Horbach

13 papers receiving 552 citations

Peers

D. A. Horbach

RHEUM

HEMAT

RNMI

IMMUN

SS Shapiro United States

JH Rand United States

Atsushi Fujisaku Japan

F Rossi France

Ken D. Pischel United States

Theo Dov Golan Israel

Stuart Weisman United States

Chung‐E Tseng United States

J R Kalden Germany

Mary M. Stimmler United States

SS Shapiro United States

D. A. Horbach

420 ×0.9

RHEUM

451 ×1.4

HEMAT

168 ×1.1

RNMI

67 ×0.7

97 ×1.1

IMMUN

Citations per year, relative to D. A. Horbach D. A. Horbach (= 1×) peers SS Shapiro

Countries citing papers authored by D. A. Horbach

Since Specialization

Citations

This map shows the geographic impact of D. A. Horbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. A. Horbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. A. Horbach more than expected).

Fields of papers citing papers by D. A. Horbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. A. Horbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. A. Horbach. The network helps show where D. A. Horbach may publish in the future.

Co-authorship network of co-authors of D. A. Horbach

This figure shows the co-authorship network connecting the top 25 collaborators of D. A. Horbach. A scholar is included among the top collaborators of D. A. Horbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. A. Horbach. D. A. Horbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Horbach, D. A., Ronald H. W. M. Derksen, Joost C. M. Meijers, et al.. (2001). Complexes of anti‐prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces. British Journal of Haematology. 113(3). 621–629. 64 indexed citations

Lisman, Ton, et al.. (1999). β2-Glycoprotein I Is Proteolytically Cleaved In Vivo upon Activation of Fibrinolysis. Thrombosis and Haemostasis. 81(1). 87–95. 33 indexed citations

Horbach, D. A., et al.. (1999). Beta2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis.. PubMed. 81(1). 87–95. 40 indexed citations

Oort, Erica van, Mariëlle J. Tempelman, Ronald H. W. M. Derksen, Philip de Groot, & D. A. Horbach. (1998). The Prevalence of a Non-phospholipid-binding Form of β2-Glycoprotein I in Human Plasma. Thrombosis and Haemostasis. 80(11). 791–797. 17 indexed citations

Donders, R C J M, L. Jaap Kappelle, R. H. W. M. Derksen, et al.. (1998). Transient monocular blindness and antiphospholipid antibodies in systemic lupus erythematosus. Neurology. 51(2). 535–540. 23 indexed citations

Oort, Erica van, Ronald H. W. M. Derksen, Philip de Groot, & D. A. Horbach. (1998). The Contribution of Anti-prothrombin-antibodies to Lupus Anticoagulant Activity. Thrombosis and Haemostasis. 79(4). 790–795. 48 indexed citations

Horbach, D. A., et al.. (1998). [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].. PubMed. 76(3). 36–40. 2 indexed citations

Horbach, D. A., Erica van Oort, Mariëlle J. Tempelman, R. H. W. M. Derksen, & P G de Groot. (1998). The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.. PubMed. 80(5). 791–7. 28 indexed citations

Horbach, D. A., Erica van Oort, R. H. W. M. Derksen, & P G de Groot. (1998). The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity--discrimination between functional and non-functional anti-prothrombin-antibodies.. PubMed. 79(4). 790–5. 56 indexed citations

10.

Fijnheer, Rob, D. A. Horbach, R C J M Donders, et al.. (1996). Factor V Leiden, Antiphospholipid Antibodies and Thrombosis in Systemic Lupus Erythematosus. Thrombosis and Haemostasis. 76(4). 514–517. 36 indexed citations

11.

Horbach, D. A., R. H. W. M. Derksen, & P. G. De Groot. (1996). The presence of anti-beta 2-glycoprotein I and anti-prothrombin antibodies and their correlations with venous and arterial thrombosis.. PubMed. 147 Suppl 1. 42–3. 4 indexed citations

12.

Horbach, D. A., et al.. (1996). Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus. Thrombosis and Haemostasis. 76(6). 916–924. 198 indexed citations

13.

Fischer, Marcel J.E., et al.. (1995). Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: Relation to lipophilicity and membrane effects. Inflammation Research. 44(2). 92–97. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact